GHDX : Summary for Genomic Health, Inc. - Yahoo Finance

U.S. Markets closed

Genomic Health, Inc. (GHDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
30.81-0.17 (-0.55%)
At close: 4:00 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close30.98
Bid24.00 x 100
Ask30.90 x 300
Day's Range30.70 - 31.18
52 Week Range22.00 - 35.79
Avg. Volume187,025
Market Cap1.03B
PE Ratio (TTM)-56.33
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire14 hours ago

    Genomic Health Announces Results from Multiple Oncotype DX® Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World

    Presentations included two overviews of prospective outcomes data and clinical evidence supporting use of the test in early-stage breast cancer patients with node-positive and node-negative disease. Data also included new results from the Surveillance, Epidemiology, and End Results (SEER) Registry program of the National Cancer Institute (NCI) analyzing outcomes and clinical utility of the Breast Recurrence Score™ (RS) in patients with high-grade tumors, and findings from a clinical evaluation of the Breast DCIS Score™ in patients with ductal carcinoma in situ (DCIS). "The clinical evidence generated by independent researchers and Genomic Health is paramount, highlighting the accuracy of Oncotype DX in predicting clinical outcomes and its unique value in providing physicians with critical genomic intelligence to enhance breast cancer treatment decisions and patient benefit," said Steven Shak, M.D., chief scientific officer, Genomic Health.

  • Genomic Health, Inc. – Value Analysis (NASDAQ:GHDX) : December 5, 2016
    Capital Cube4 days ago

    Genomic Health, Inc. – Value Analysis (NASDAQ:GHDX) : December 5, 2016

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Genomic Health, Inc. a score of 41. Our analysis is based on comparing Genomic Health, Inc. with the following peers – Quest Diagnostics Incorporated, Trovagene, Inc., Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Response Genetics, Inc., Foundation Medicine, Inc., Biocept, Inc., QIAGEN NV, NeoGenomics, Inc. and ... Read more (Read more...)

  • Hedge Funds Begin to Sour on Kulicke and Soffa Industries Inc. (KLIC)
    Insider Monkey7 days ago

    Hedge Funds Begin to Sour on Kulicke and Soffa Industries Inc. (KLIC)

    You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make proper and accurate analysis of certain small-cap companies. However, well-known and successful hedge fund investors like Carl Icahn and George […]